1. Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center 
Patrick Hoversten, Fouad Otaki, David A. Katzka 
Clinical Gastroenterology and Hepatology 
Volume 17, Issue 1, Pages e1 (January 2019)
DOI: /j.cgh
Copyright © 2019 AGA Institute Terms and Conditions

2. Figure 1
(A) Top 8 risk factors in the 3 cohorts. Risk factors were reported as percentages and compared among the 3 group. (B) Distribution of endoscopic findings for all 3 groups. (Bi) Asymptomatic patients. (Bii) Symptomatic patients without cause. (Biii) Symptomatic patients with cause. (C) Flow chart of patient outcomes after treatment or observation after diagnosis of esophageal candidiasis. H2A, histamine 2 receptor antagonist; PPI, proton pump inhibitor.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2019 AGA Institute Terms and Conditions